Sample analysis drives revenue, while method development is overhead. The price per sample does not move; the lever is what each run delivers.
4-channel setup with up to 4 ligands per channel, so panels that previously required multiple assays can run as one method.
Clinical and GLP studies need every sample run the same way, with calibration and controls throughout the sequence.
Read PK, immunogenicity, and soluble biomarkers with one assay. Run up to 768 samples, unattended, with reference and control in the same sequence.
Years of optimising Surface Plasmon Resonance (SPR) assays should not be lost when adopting a new platform.
Nanophotonic Evanescent-field Sensing (NES) preserves familiar kinetic workflows while adding 16-plex measurements, high sensitivity, and compact hardware.
Clinical and process samples are valuable, limited, and rarely arrive in ideal conditions.
The antifouling hydrogel maintains clean signals in complex matrices, while multiplexed measurements extract more data from every injection.
inQuiQ 768 runs up to 768 samples, injected one after another, from 2×96 or 2×384 well plates. Runs are unattended, and saved assay sequences hold the method constant across the series so calibration, controls, and study samples are treated identically.
With in-flow immobilisation, the capture molecules are introduced through the fluidic channels and immobilised directly onto the sensor surfaces. The inQuiQ has 4 independent flow channels, allowing different surfaces to be prepared in parallel while keeping the setup simple and reproducible.
To analyse a full 16-plex panel, you can also use a spotter to prepare the chip. A spotter precisely deposits different capture molecules onto defined sensor locations, allowing each of the 16 sensors to carry a different target. This is done as a separate chip-preparation step before the measurement.
In many cases, yes. Targets for PK, immunogenicity, and soluble biomarkers can be placed on the same chip and read from one injection, which replaces several single-analyte assays with one method. Assay design is confirmed with an application scientist before transfer.
Yes. The antifouling hydrogel surface limits non-specific binding in serum, plasma, CSF, and culture supernatant, and unpurified samples run directly once filtered through a 0.22 µm filter. Reference channel subtraction removes bulk refractive index and matrix effects.